A combined postoperative nomogram for survival prediction in clear cell renal carcinoma
- PMID: 34647146
- DOI: 10.1007/s00261-021-03293-4
A combined postoperative nomogram for survival prediction in clear cell renal carcinoma
Abstract
Purpose: To investigate and validate the prognostic value of nomogram models for predicting disease-free survival (DFS) and overall survival (OS) in patients with clear cell renal cell carcinoma (ccRCC).
Methods: In this retrospective study, 223 patients (age 54.38 ± 10.93 years) with pathologically confirmed ccRCC who underwent resection and lymph node dissection between March 2010 and September 2018 were investigated. All patients were randomly divided into training (n = 155) and validation (n = 68) cohorts. Radiomics features were extracted from computed tomography (CT) images in the unenhanced, corticomedullary, and nephrographic phases. Radiomic score was calculated and combined with clinicopathological factors for model construction and nomogram development. Clinicopathological factors and imaging features were collected at initial diagnosis. Univariate and multivariate Cox proportional hazards regression analyses were used to evaluate the relationship between the radiomics signature and prognosis outcomes.
Results: There were four prognostic factors for predicting DFS and five factors for predicting OS in our nomogram model (P < 0.05). The radiomics signature correlated independently with DFS (hazard ratio = 27; P < 0.001) and OS (hazard ratio = 25; P < 0.001). The nomogram showed excellent performance (C-index = 0.825) for predicting DFS. The combined nomogram also showed the highest C-index for OS (C-index = 0.943), which was verified in the validation dataset.
Conclusion: The combined nomogram model based on radiomics, clinicopathological factors, and preoperative CT features can accurately perform prognosis and survival analysis and can potentially be used for preoperative non-invasive survival prediction in ccRCC patients.
Keywords: Clear cell renal cell carcinoma; Nomogram; Prognosis; Survival analysis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.Eur Radiol. 2020 Feb;30(2):1274-1284. doi: 10.1007/s00330-019-06427-x. Epub 2019 Sep 10. Eur Radiol. 2020. PMID: 31506816
-
Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study.Cancer Imaging. 2024 Aug 6;24(1):103. doi: 10.1186/s40644-024-00744-1. Cancer Imaging. 2024. PMID: 39107799 Free PMC article.
-
Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.Eur Radiol. 2021 Aug;31(8):6078-6086. doi: 10.1007/s00330-020-07667-y. Epub 2021 Jan 29. Eur Radiol. 2021. PMID: 33515086
-
Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.Cancer Med. 2023 Mar;12(6):7627-7638. doi: 10.1002/cam4.5449. Epub 2022 Nov 17. Cancer Med. 2023. PMID: 36397666 Free PMC article.
-
Development and validation of a CT based radiomics nomogram for preoperative prediction of ISUP/WHO grading in renal clear cell carcinoma.Abdom Radiol (NY). 2025 Mar;50(3):1228-1239. doi: 10.1007/s00261-024-04576-2. Epub 2024 Sep 23. Abdom Radiol (NY). 2025. PMID: 39311950
Cited by
-
Development and validation of a nomogram for predicting the impact of tumor size on cancer-specific survival of locally advanced renal cell carcinoma: a SEER-based study.Aging (Albany NY). 2024 Feb 19;16(4):3823-3836. doi: 10.18632/aging.205562. Epub 2024 Feb 19. Aging (Albany NY). 2024. PMID: 38376430 Free PMC article.
-
Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy.Cancers (Basel). 2024 Aug 7;16(16):2786. doi: 10.3390/cancers16162786. Cancers (Basel). 2024. PMID: 39199559 Free PMC article.
-
Establishment and validation of the survival prediction risk model for appendiceal cancer.Front Med (Lausanne). 2022 Oct 28;9:1022595. doi: 10.3389/fmed.2022.1022595. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36388937 Free PMC article.
-
Development of a combined radiomics and CT feature-based model for differentiating malignant from benign subcentimeter solid pulmonary nodules.Eur Radiol Exp. 2024 Jan 17;8(1):8. doi: 10.1186/s41747-023-00400-6. Eur Radiol Exp. 2024. PMID: 38228868 Free PMC article.
-
Development of a CT radiomics prognostic model for post renal tumor resection overall survival based on transformer enhanced K-means clustering.Med Phys. 2025 May;52(5):3243-3257. doi: 10.1002/mp.17639. Epub 2025 Jan 27. Med Phys. 2025. PMID: 39871101 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590 - DOI - PubMed
-
- Brufau BPO, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN (2013) Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics 33:1691–1716. https://doi.org/10.1148/rg.336125110 - DOI
-
- Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453. https://doi.org/10.1148/radiol.13112617 - DOI
-
- Capitanio U, Montorsi F (2016) Renal cancer. Lancet 387:894–906. https://doi.org/10.1016/S0140-6736(15)00046-X - DOI
-
- Wang Z, Xie H, Guo L, Cai Q, Shang Z, Jiang N, Niu Y (2017) Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals. Cancer Manag Res 9:679–689. https://doi.org/10.2147/CMAR.S141670 - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical